PMID: 517778Dec 1, 1979Paper

Propranolol binding in plasma during cardiopulmonary bypass

Anesthesiology
M WoodA J Wood

Abstract

The effect of cardiopulmonary bypass on the plasma binding of propranolol was examined in seven patients. The fraction of propranolol free in plasma doubled, increasing from 6.6 to 13.5 per cent (P less than 0.001) following the administration of heparin, 400 IU/kg. Once cardiopulmonary bypass was concluded and protamine, 8 mg/kg, given, the free fraction decreased from 13.4 to 8.7 per cent (P less than 0.005). There was a further significant decrease to 6.5 per cent over the next 3.1 hours (SE +/- 0.3). Those alterations in the free fraction, which would result in more drug being available for binding to receptor sites and for exerting its pharmacologic effect, were due principally to the changes in free fatty acid levels produced by heparin and protamine, but also to the hemodilution produced by the pump prime.

Citations

Mar 14, 2000·Acta Anaesthesiologica Scandinavica·B Mets
Jun 1, 1989·Antimicrobial Agents and Chemotherapy·G L JungbluthW J Jusko
Jun 1, 1991·Journal of Cardiothoracic and Vascular Anesthesia·L Landow, J Wilson
Jun 1, 1992·Journal of Cardiothoracic and Vascular Anesthesia·J M den HollanderJ G Bovill
Jun 1, 1990·Journal of Cardiothoracic Anesthesia·L LandowM Pasque
Feb 1, 1983·British Journal of Clinical Pharmacology·J S WalkerC A Shanks
Jan 1, 1989·Biopharmaceutics & Drug Disposition·L M DubéI J McGilveray
Dec 1, 1980·Biochemical Pharmacology·K M GiacominiT F Blaschke
Mar 20, 2015·Anesthesia and Analgesia·Aaron E BarryMartin J London
May 27, 2005·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M J C CarmonaS R C J Santos
Oct 28, 2019·CPT: Pharmacometrics & Systems Pharmacology·Christoph P HornikMichael Cohen-Wolkowiez
Dec 1, 1980·British Journal of Clinical Pharmacology·A J WoodD G Shand
Feb 1, 1980·British Journal of Clinical Pharmacology·P V DesmondS Schenker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.